Since PSGR expression is strongly up-regulated in human prostate cancers, PSGR-derived peptides may serve as diagnostic tools or immunotherapeutic targets of anticancer vaccines alone or in combination with other epitopes that are derived from other prostate-specific antigens. The gene discussed is OR51E2; the disease is Familial prostate cancer.